StockData
Imunon, Inc. logo

Imunon, Inc. (IMNN) stock

IMNNNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q1 FY2026, quarter ended Mar 31, 2026Last filing: 10-Q on Nov 12, 2026Score 6/30
$0.58−0.03 (-5.26%)

Close on Nov 18, 2026Market cap $3.25MP/E –Yield –

Imunon revenue

Revenue is the money a company takes in from selling its products and services, before any costs are deducted.

Imunon's revenue for the twelve months ending Dec 31, 2022 was $500.00K, up 0.0% year over year. For fiscal 2022 it was $500.00K, up 0.0% from the year before. The highest annual figure on record is $500.00K in fiscal 2017.

Annual revenue

PeriodPeriod endValueChange
FY2022Dec 31, 2022$500.00K0.0%
FY2021Dec 31, 2021$500.00K0.0%
FY2020Dec 31, 2020$500.00K0.0%
FY2019Dec 31, 2019$500.00K0.0%
FY2018Dec 31, 2018$500.00K0.0%
FY2017Dec 31, 2017$500.00K–

Quarterly revenue

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q4 FY2022Dec 31, 2022$125.00K0.0%
Q3 FY2022Sep 30, 2022$125.00K0.0%
Q2 FY2022Jun 30, 2022$125.00K0.0%
Q1 FY2022Mar 31, 2022$125.00K0.0%
Q4 FY2021Dec 31, 2021$125.00K0.0%
Q3 FY2021Sep 30, 2021$125.00K0.0%
Q2 FY2021Jun 30, 2021$125.00K0.0%
Q1 FY2021Mar 31, 2021$125.00K0.0%
Q4 FY2020Dec 31, 2020$125.00K0.0%
Q3 FY2020Sep 30, 2020$125.00K0.0%
Q2 FY2020Jun 30, 2020$125.00K0.0%
Q1 FY2020Mar 31, 2020$125.00K0.0%
Q4 FY2019Dec 31, 2019$125.00K0.0%
Q3 FY2019Sep 30, 2019$125.00K0.0%
Q2 FY2019Jun 30, 2019$125.00K0.0%
Q1 FY2019Mar 31, 2019$125.00K0.0%
Q4 FY2018Dec 31, 2018$125.00K0.0%
Q3 FY2018Sep 30, 2018$125.00K0.0%
Q2 FY2018Jun 30, 2018$125.00K0.0%
Q1 FY2018Mar 31, 2018$125.00K0.0%
Q4 FY2017Dec 31, 2017$125.00K–
Q3 FY2017Sep 30, 2017$125.00K–
Q2 FY2017Jun 30, 2017$125.00K–
Q1 FY2017Mar 31, 2017$125.00K–

More Imunon figures

See a number that looks wrong?